Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Risk of venous thromboembolism in patients with psoriatic arthritis, psoriasis and rheumatoid arthritis: a general population-based cohort study
Alexis Ogdie, Neilia Kay McGill, Daniel B. Shin, et al.
European Heart Journal (2017) Vol. 39, Iss. 39, pp. 3608-3614
Open Access | Times Cited: 128

Showing 26-50 of 128 citing articles:

Safety and Efficacy of Filgotinib: Up to 4-year Results From an Open-label Extension Study of Phase II Rheumatoid Arthritis Programs
Arthur Kavanaugh, René Westhovens, Kevin Winthrop, et al.
The Journal of Rheumatology (2021) Vol. 48, Iss. 8, pp. 1230-1238
Open Access | Times Cited: 40
Safety Profile of Upadacitinib up to 3 Years in Psoriatic Arthritis: An Integrated Analysis of Two Pivotal Phase 3 Trials
Gerd R Burmester, Kevin Winthrop, Ricardo Blanco, et al.
Rheumatology and Therapy (2021) Vol. 9, Iss. 2, pp. 521-539
Open Access | Times Cited: 36
Risk of venous thromboembolism associated with Janus kinase inhibitors for rheumatoid arthritis: case presentation and literature review
Shunsuke Mori, Fumihiko Ogata, Ryusuke Tsunoda
Clinical Rheumatology (2021) Vol. 40, Iss. 11, pp. 4457-4471
Open Access | Times Cited: 34
Recommendations from the ICM-VTE: General

Journal of Bone and Joint Surgery (2022) Vol. 104, Iss. Suppl 1, pp. 4-162
Open Access | Times Cited: 25
MACE and VTE across upadacitinib clinical trial programmes in rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis
Christina Charles‐Schoeman, Ernest Choy, Iain B. McInnes, et al.
RMD Open (2023) Vol. 9, Iss. 4, pp. e003392-e003392
Open Access | Times Cited: 16
A Practical Guide to Using Oral JAK Inhibitors for Atopic Dermatitis from the International Eczema Council
Carter Haag, Andrew Alexis, Valéria Aoki, et al.
British Journal of Dermatology (2024)
Open Access | Times Cited: 5
The Risk of Systemic Diseases in Those with Psoriasis and Psoriatic Arthritis: From Mechanisms to Clinic
Yu Ri Woo, Chul Jong Park, Hoon Kang, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 19, pp. 7041-7041
Open Access | Times Cited: 38
Hematological Manifestations among Patients with Rheumatic Diseases
Alina Klein, Yair Molad
Acta Haematologica (2020) Vol. 144, Iss. 4, pp. 403-412
Open Access | Times Cited: 38
Risk of venous thromboembolism in knee, hip and hand osteoarthritis: a general population-based cohort study
Chao Zeng, Kim L. Bennell, Zidan Yang, et al.
Annals of the Rheumatic Diseases (2020) Vol. 79, Iss. 12, pp. 1616-1624
Open Access | Times Cited: 35
Safety of Janus Kinase Inhibitors in Older Patients: A Focus on the Thromboembolic Risk
Suraj Rajasimhan, Ömer Nurı Pamuk, James D. Katz
Drugs & Aging (2020) Vol. 37, Iss. 8, pp. 551-558
Open Access | Times Cited: 34
Incidence of Venous Thromboembolism in Patients With Dermatologist-Diagnosed Chronic Inflammatory Skin Diseases
Maria C. Schneeweiss, Seoyoung C. Kim, Richard Wyss, et al.
JAMA Dermatology (2021) Vol. 157, Iss. 7, pp. 805-805
Open Access | Times Cited: 29
Incidence of Cardiovascular Disease and Venous Thromboembolism in Patients With Atopic Dermatitis
Joy Wan, Zelma C. Chiesa Fuxench, Sonia Wang, et al.
The Journal of Allergy and Clinical Immunology In Practice (2023) Vol. 11, Iss. 10, pp. 3123-3132.e3
Closed Access | Times Cited: 13
Risk Stratification of Patients with Psoriatic Arthritis and Ankylosing Spondylitis for Treatment with Tofacitinib: A Review of Current Clinical Data
Lars Erik Kristensen, Atul Deodhar, Ying Ying Leung, et al.
Rheumatology and Therapy (2024) Vol. 11, Iss. 3, pp. 487-499
Open Access | Times Cited: 4
Psoriasis and cardiovascular disease: the elusive link
Antonis A. Manolis, Theodora A. Manolis, Helen Melita, et al.
International Reviews of Immunology (2018) Vol. 38, Iss. 1, pp. 33-54
Closed Access | Times Cited: 37
Risk of venous thromboembolism in ankylosing spondylitis: a general population-based study
J. Antonio Aviña‐Zubieta, Jonathan Chan, Mary A. De Vera, et al.
Annals of the Rheumatic Diseases (2019) Vol. 78, Iss. 4, pp. 480-485
Closed Access | Times Cited: 34
Updated clinical models for VTE prediction in hospitalized medical patients
Grigoris Gerotziafas, Loula Papageorgiou, Stella Salta, et al.
Thrombosis Research (2018) Vol. 164, pp. S62-S69
Closed Access | Times Cited: 33
Platelet Dysfunction and Its Role in the Pathogenesis of Psoriasis
Zhijia Fan, Li Wang, Haoqin Jiang, et al.
Dermatology (2020) Vol. 237, Iss. 1, pp. 56-65
Open Access | Times Cited: 30
Risk of venous thromboembolism in immune-mediated inflammatory diseases: a UK matched cohort study
James Galloway, Kevin Barrett, Peter M. Irving, et al.
RMD Open (2020) Vol. 6, Iss. 3, pp. e001392-e001392
Open Access | Times Cited: 29
Use of Glucocorticoids and Risk of Venous Thromboembolism: A Narrative Review
Chiara Simion, Elena Campello, Elisa Bensi, et al.
Seminars in Thrombosis and Hemostasis (2021) Vol. 47, Iss. 06, pp. 654-661
Closed Access | Times Cited: 25
Comparative safety of Janus kinase inhibitors and tumor necrosis factor inhibitors in patients undergoing treatment for rheumatoid arthritis
Yao‐Fan Fang, Jia‐Rou Liu, Shu‐Hao Chang, et al.
International Journal of Rheumatic Diseases (2022) Vol. 25, Iss. 11, pp. 1254-1262
Closed Access | Times Cited: 18
Management of Psoriatic Arthritis in Patients With Comorbidities: An Updated Literature Review Informing the 2021 GRAPPA Treatment Recommendations
Cristiano Campanholo, Ajesh B. Maharaj, Nadia Corp, et al.
The Journal of Rheumatology (2022), pp. jrheum.220310-jrheum.220310
Open Access | Times Cited: 18
Pharmacological prophylaxis of venous thromboembolism in surgical patients
S.I. Savoliuk, Л. Б. Бондаренко
EMERGENCY MEDICINE (2025) Vol. 20, Iss. 8, pp. 670-687
Open Access
The role of mediators in the formation of leading pathological processes in psoriatic arthritis
D. A. Pogonchenkova, L. V. Chetvernya, Olga A. Vasil'yeva, et al.
Bulletin of Siberian Medicine (2025) Vol. 23, Iss. 4, pp. 187-196
Open Access
Venous Thromboembolism: Risk Assessment and Prophylaxis in the Medically Ill
John Stewart, Lily Ackermann, Geno J. Merli, et al.
(2025), pp. 1-24
Closed Access
Haemostatic imbalance in a patient with psoriasis
Athira Sasidharan, R. Mohamed
The Journal of Clinical and Scientific Research (2025)
Open Access

Scroll to top